Dong Lu

4.1k citations

100 papers · 3.0k indexed · h-index 26

Impact in

Cancer Research top 5%
- MicroRNA in disease regulation
Molecular Biology top 5%
- CRISPR and Genetic Engineering
- Pluripotent Stem Cells Research
- Protein Degradation and Inhibitors
- RNA Interference and Gene Delivery

Papers in ⓘ

Hepatology 16
- Hepatocellular Carcinoma Treatment and Prognosis 8
Immunology and Allergy 9
- Cell Adhesion Molecules Research 8

Co-authors: Pentao Liu (7 shared papers)Elena Vigorito (4 shared papers)Rebecca Leyland (3 shared papers)Susan Kohlhaas (1 shared paper)Xinjie Lu (10 shared papers)Allan Bradley (3 shared papers)Lia S. Campos (5 shared papers)Vijay V. Kakkar (6 shared papers)
Journals: European Journal of Medicinal Chemistry (6 papers)ACS Medicinal Chemistry Letters (4 papers)Journal of Medicinal Chemistry (3 papers)PLoS ONE (3 papers)Nature Communications (2 papers)
Partner nations: China United States United Kingdom

In The Last Decade

Dong Lu

98 papers receiving 3.0k citations

Peers

Countries citing papers authored by Dong Lu

Since Specialization

Citations

This map shows the geographic impact of Dong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Lu more than expected).

Fields of papers citing papers by Dong Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Lu. The network helps show where Dong Lu may publish in the future.

Co-authors

The 25 scholars most cited alongside Dong Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dong Lu Line = papers co-authored together Dong Lu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Chromosomal transposition of PiggyBac in mouse embryonic stem cells Proceedings of the National Academy of Sciences ·Wei Wang, Chengyi Lin, Dong Lu, Zemin Ning, Tony Cox, David Melvin, Xiaozhong Wang, Allan Bradley, Pentao Liu	2008	299
2	Reprogramming of T Cells to Natural Killer–Like Cells upon Bcl11b Deletion Science ·Peng Li, Shannon Burke, Juexuan Wang, Xiongfeng Chen, Mariaestela Ortiz, Song-Choon Lee, Dong Lu, Lia S. Campos, David Goulding, Bee Ling Ng, Gordon Dougan, Brian J.P. Huntly, Berthold Göttgens, Nancy A. Jenkins, Neal G. Copeland, Francesco Colucci, Pentao Liu	2010	267
3	miR‐155: an ancient regulator of the immune system Immunological Reviews ·Elena Vigorito, Susan Kohlhaas, Dong Lu, Rebecca Leyland	2013	259
4	Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1 Proceedings of the National Academy of Sciences ·Wei Wang, Jian Yang, Hui Liu, Dong Lu, Xiongfeng Chen, Ζήνων Ζήνωνος, Lia S. Campos, Roland Rad, Ge Guo, Shujun Zhang, Allan Bradley, Pentao Liu	2011	193
5	PiggyBac Transposon Mutagenesis: A Tool for Cancer Gene Discovery in Mice Science ·Roland Rad, Lena Rad, Wei Wang, Juan Cadiñanos, George S. Vassiliou, Stephen Rice, Lia S. Campos, Kosuke Yusa, Ruby Banerjee, Meng Amy Li, Jorge de la Rosa, Alexander Strong, Dong Lu, Peter Ellis, Nathalie Conte, Fengtang Yang, Pentao Liu, Allan Bradley	2010	182
6	Artificial intelligence in drug design Science China Life Sciences ·Feisheng Zhong, Jing Xing, Xutong Li, Xiaohong Liu, Zunyun Fu, Zhaoping Xiong, Dong Lu, Xiaolong Wu, Jihui Zhao, Xiaoqin Tan, Fei Li, Xiaomin Luo, Zhaojun Li, Kaixian Chen, Mingyue Zheng, Hualiang Jiang	2018	158
7	Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry Nature Communications ·Wenhao Guo, Xiaoli Qi, Xin Yu, Yang Liu, Chan-I Chung, Fang Bai, Xingcheng Lin, Dong Lu, Lingfei Wang, Jianwei Chen, Lynn Su, Krystle Nomie, Feng Li, Meng C. Wang, Xiaokun Shu, José N. Onuchic, Jennifer A. Woyach, Michael Wang, Jin Wang	2020	152
8	Time–Temperature Indicator for Perishable Products Based on Kinetically Programmable Ag Overgrowth on Au Nanorods ACS Nano ·Chao Zhang, Anxiang Yin, Ruibin Jiang, Jie Rong, Dong Lu, Tian Zhao, Ling‐Dong Sun, Jianfang Wang, Xing Chen, Chun‐Hua Yan	2013	150
9	The miR-155–PU.1 axis acts on Pax5 to enable efficient terminal B cell differentiation The Journal of Experimental Medicine ·Dong Lu, Rinako Nakagawa, Sandra Lazzaro, Philipp Staudacher, Cei Abreu‐Goodger, Tom Henley, Sara Boiani, Rebecca Leyland, Alison Galloway, Simon Andrews, Geoffrey W. Butcher, Stephen L. Nutt, Martin Turner, Elena Vigorito	2014	70
10	MiR-25 Regulates Wwp2 and Fbxw7 and Promotes Reprogramming of Mouse Fibroblast Cells to iPSCs PLoS ONE ·Dong Lu, Matthew P. Davis, Cei Abreu‐Goodger, Wei Wang, Lia S. Campos, Julia Siede, Elena Vigorito, William C. Skarnes, Ian Dunham, Anton J. Enright, Pentao Liu	2012	56
11	Targeted Protein Degradation via Lysosomes Biochemistry ·Rishi R. Paudel, Dong Lu, Sandipan Chowdhury, Erika Y. Monroy, Jin Wang	2022	55
12	A Novel Pyridazinone Derivative Inhibits Hepatitis B Virus Replication by Inducing Genome-Free Capsid Formation Antimicrobial Agents and Chemotherapy ·Yajuan Wang, Dong Lu, Yi-Bin Xu, Weiqiang Xing, Xiankun Tong, Guifeng Wang, Chunlan Feng, Pei‐Lan He, Li Yang, Wei Tang, Youhong Hu, Jianping Zuo	2015	49
13	Design, Synthesis, and Biological Evaluation of the First c-Met/HDAC Inhibitors Based on Pyridazinone Derivatives ACS Medicinal Chemistry Letters ·Dong Lu, Juan Yan, Lang Wang, Hong‐Chun Liu, Limin Zeng, Minmin Zhang, Wenwen Duan, Yinchun Ji, Jingchen Cao, Meiyu Geng, Aijun Shen, Youhong Hu	2017	43
14	Liver Abscess Formation Following Transarterial Chemoembolization Medicine ·Wei‐Fu Lv, Dong Lu, Yusheng He, Jingkun Xiao, Chunze Zhou, Delei Cheng	2016	41
15	The Role of Integrins in Cancer and the Development of Anti-Integrin Therapeutic Agents for Cancer Therapy Xinjie Lu, Dong Lu, Mike Scully, Vijay V. Kakkar	2008	40
16	MicroRNA-155 controls affinity-based selection by protecting c-MYC+ B cells from apoptosis Journal of Clinical Investigation ·Rinako Nakagawa, Rebecca Leyland, Michael Meyer‐Hermann, Dong Lu, Martin Turner, Giuseppina Arbore, Tri Giang Phan, Robert Brink, Elena Vigorito	2015	39
17	The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy. PubMed ·Xinjie Lu, Dong Lu, Mike Scully, Vijay V. Kakkar	2008	39
18	ADAM Proteins- Therapeutic Potential in Cancer Current Cancer Drug Targets ·Xinjie Lu, Dong Lu, Mike Scully, Vijay V. Kakkar	2008	38
19	Discovery of novel 2,6-disubstituted pyridazinone derivatives as acetylcholinesterase inhibitors European Journal of Medicinal Chemistry ·Weiqiang Xing, Yan Fu, Zhangxing Shi, Dong Lu, Haiyan Zhang, Youhong Hu	2013	37
20	Enhancing the cellular anti-proliferation activity of pyridazinones as c-met inhibitors using docking analysis European Journal of Medicinal Chemistry ·Weiqiang Xing, Jing Ai, Shiyu Jin, Zhangxing Shi, Peng Xia, Lang Wang, Yinchun Ji, Dong Lu, Yang Liu, Meiyu Geng, Youhong Hu	2015	35

About Dong Lu

Dong Lu is a scholar working on Hepatology, Immunology and Allergy, Cancer Research, Biological Psychiatry and Computational Theory and Mathematics, having authored 100 papers that have together received 3.0k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Protein Degradation and Inhibitors (8 papers), Cell Adhesion Molecules Research (8 papers), MicroRNA in disease regulation (7 papers), Ubiquitin and proteasome pathways (7 papers), RNA Interference and Gene Delivery (6 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Cancer Research (409 citations), Molecular Biology (1.8k citations), Hepatology (171 citations), Immunology (454 citations) and Immunology and Allergy (129 citations). Dong Lu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Pentao Liu, Elena Vigorito, Rebecca Leyland, Susan Kohlhaas, Xinjie Lu, Allan Bradley, Lia S. Campos, Vijay V. Kakkar, Zemin Ning and Xiaozhong Wang. Their work appears in journals such as European Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, Journal of Medicinal Chemistry, PLoS ONE and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact